Genetic Testing to Personalize GLP-1 Selection After Surgery Not all post-bypass patients respond equally to GLP-1 therapy because genetic variation in appetite-control pathways influences medication efficacy
Nevertheless, the presence of impaired G6PD activity may result in ROS accumulation, causing severe hemolysis
Chief Scientific Officer Chris Boshoff told CNBC that the vast majority of patients will prefer an injection, and "obviously, being monthly will be preferable over weekly, and likely three-monthly maybe better than monthly." But List said it's still early days for that drug
The promise is compelling: access to medications containing compounded formulations of the active ingredient as Wegovy, Ozempic, Mounjaro, and Zepbound, often at a fraction of the brand-name cost
Additionally, changes in dietary patterns during treatment could affect warfarin anticoagulation stability, and closer INR monitoring is warranted